The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...

President Trump will continue to pursue the policy of Medicare ... said the CMS in its statement. Trump is planning to issue an executive order supporting drug price negotiations under the IRA ...

The National Community Pharmacists Association has told CMS that more than 90% of independent pharmacies may choose to stop stocking drugs included in the Medicare Drug Price Negotiation Program due ...

AAM said that by including drugs with generics and biosimilars in development in the 15 drugs selected for negotiation, CMS ...

President Donald Trump’s Medicare agency is seeking to bring more transparency to the US government’s drug price negotiation ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

Robert F. Kennedy Jr. said he would follow the Trump administration’s orders on prescription drug price negotiations, a ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.